"This SPA agreement marks an important milestone in the development of Descartes-08 for MG, providing critical regulatory clarity and a clear path toward potential approval,” said Carsten Brunn, Ph.D.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Lehigh Valley’s health networks are seeing abnormally high cases of the stomach bug that’s taking a large number of people ...

Andrew Teschendorff, Professor at the Chinese Academy of Sciences, is developing computational systems-biological tools to ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

Looking to the future, Suven’s Horizon 2 initiative – which includes plans to incorporate capabilities in flow chemistry, ...

H.C. Wainwright revised its price target for Personalis (NASDAQ:PSNL) shares, dropping it to $8.00 from the previous $11.00. Despite this reduction, the firm maintained a Buy rating on the company's ...